SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

NCT01542294 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: s1
DRUG: Oxaliplatin

Sponsor

Chinese Academy of Medical Sciences